Cargando…

A Personalized Medicine Approach Using Clinical Utility Index and Exposure‐Response Modeling Informed by Patient Preferences Data

Selection of a personalized dose for an individual patient can be informed by the patient’s preferences, translated as weights on each of the clinically relevant safety and efficacy drug attributes, based on results from a brief patient preference elicitation questionnaire. In this analysis, the wei...

Descripción completa

Detalles Bibliográficos
Autores principales:	Winzenborg, Insa, Soliman, Ahmed M., Shebley, Mohamad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825192/ https://www.ncbi.nlm.nih.gov/pubmed/33200566 http://dx.doi.org/10.1002/psp4.12570

Ejemplares similares

Interdisciplinary model‐informed drug development for extending duration of elagolix treatment in patients with uterine fibroids
por: Beck, Denise, et al.
Publicado: (2022)

Integrating real‐world data and modeling to project changes in femoral neck bone mineral density and fracture risk in premenopausal women
por: Beck, Denise, et al.
Publicado: (2021)

Validation of a quantitative systems pharmacology model of calcium homeostasis using elagolix Phase 3 clinical trial data in women with endometriosis
por: Stodtmann, Sven, et al.
Publicado: (2021)

Population Pharmacokinetics of Elagolix in Combination with Low-Dose Estradiol/Norethindrone Acetate in Women with Uterine Fibroids
por: Beck, Denise, et al.
Publicado: (2021)

Clinical Pharmacology of Elagolix: An Oral Gonadotropin-Releasing Hormone Receptor Antagonist for Endometriosis
por: Shebley, Mohamad, et al.
Publicado: (2019)

Effect of Elagolix Exposure on Clinical Efficacy End Points in Phase III Trials in Women With Endometriosis‐Associated Pain: An Application of Markov Model
por: Winzenborg, Insa, et al.
Publicado: (2020)

Exposure–Response Analyses of Upadacitinib Efficacy and Safety in Phase II and III Studies to Support Benefit–Risk Assessment in Rheumatoid Arthritis
por: Nader, Ahmed, et al.
Publicado: (2019)

Exposure‐Safety Analyses Identify Predictors of Change in Bone Mineral Density and Support Elagolix Labeling for Endometriosis‐Associated Pain
por: Abbas Suleiman, Ahmed, et al.
Publicado: (2020)

Physiologically based pharmacokinetic modeling and simulations to inform dissolution specifications and clinical relevance of release rates on elagolix exposure
por: Mukherjee, Dwaipayan, et al.
Publicado: (2022)

Interaction of Dasabuvir With Clopidogrel: Did Predictions by Physiologically Based Pharmacokinetics Modeling Pass the Test?
por: Shebley, Mohamad
Publicado: (2018)

Effects of elagolix on the pharmacokinetics of omeprazole and its metabolites in healthy premenopausal women
por: Nader, Ahmed, et al.
Publicado: (2022)

Preferred Sources of Health Information in Persons With Multiple Sclerosis: Degree of Trust and Information Sought
por: Marrie, Ruth Ann, et al.
Publicado: (2013)

Evaluating preference weights for the Asthma Symptom Utility Index (ASUI) across countries
por: Flood, Emuella M, et al.
Publicado: (2006)

Implementation and utilization of genetic testing in personalized medicine
por: Abul-Husn, Noura S, et al.
Publicado: (2014)

German and Italian Users of Web-Accessed Genetic Data: Attitudes on Personal Utility and Personal Sharing Preferences. Results of a Comparative Survey (n=192)
por: Wöhlke, Sabine, et al.
Publicado: (2020)

Personalized Nutrition Advice: Preferred Ways of Receiving Information Related to Psychological Characteristics
por: Dijksterhuis, Garmt B., et al.
Publicado: (2021)

Vulnerability- and Diversity-Aware Anonymization of Personally Identifiable Information for Improving User Privacy and Utility of Publishing Data
por: Majeed, Abdul, et al.
Publicado: (2017)

Guiding dose adjustment of amlodipine after co-administration with ritonavir containing regimens using a physiologically-based pharmacokinetic/pharmacodynamic model
por: Mukherjee, Dwaipayan, et al.
Publicado: (2018)

Quantitative Assessment of Elagolix Enzyme-Transporter Interplay and Drug–Drug Interactions Using Physiologically Based Pharmacokinetic Modeling
por: Chiney, Manoj S., et al.
Publicado: (2019)

Public preferences for communicating personal genomic risk information: a focus group study
por: Smit, Amelia K., et al.
Publicado: (2015)

Sex and gender differences in technology needs and preferences among informal caregivers of persons with dementia
por: Xiong, Chen, et al.
Publicado: (2020)

Multiple sclerosis: clinical profiling and data collection as prerequisite for personalized medicine approach
por: Ziemssen, Tjalf, et al.
Publicado: (2016)

Utilization of a Parental Approach to Informed Consent in Intravenous Tissue Plasminogen Activator Administration Decision-Making: Patient Preference and Ethical Considerations
por: Murray, Ann M., et al.
Publicado: (2019)

Implementing personalized medicine with asymmetric information on prevalence rates
por: Antoñanzas, Fernando, et al.
Publicado: (2016)

How to Utilize Clinical and Genetic Information for Personalized Treatment of Major Depressive Disorder: Step by Step Strategic Approach
por: Fabbri, Chiara, et al.
Publicado: (2020)

Electrical Tortuosity Index: A New Approach for Identifying Rock Typing to Enhance Reservoir Characterization Using Well-Log Data of Uncored Wells
por: Shahat, John S., et al.
Publicado: (2023)

Music Preferences and Personality in Brazilians
por: Herrera, Lucia, et al.
Publicado: (2018)

Personality types revisited–a literature-informed and data-driven approach to an integration of prototypical and dimensional constructs of personality description
por: Kerber, André, et al.
Publicado: (2021)

Personalized Route Planning System Based on Driver Preference
por: Wang, Ren, et al.
Publicado: (2021)

Epidemiologic approaches to persons with exposures to waste chemicals.
por: Landrigan, P J
Publicado: (1983)

ASSESSING PREFERENCES FOR COMMUNICATING WITH TECHNOLOGY: A PERSON-CENTERED APPROACH TO CARE MANAGEMENT
por: Sillner, Andrea, et al.
Publicado: (2022)

Utilization of genetic information for medicines development and equitable benefit sharing
por: Matsuyama, Kotone, et al.
Publicado: (2023)

Precision Medicine Approaches to Diabetic Kidney Disease: Personalized Interventions on the Horizon
por: Nageeta, FNU, et al.
Publicado: (2023)

Estimating a Preference-Based Index for Mental Health From the Recovering Quality of Life Measure: Valuation of Recovering Quality of Life Utility Index
por: Keetharuth, Anju Devianee, et al.
Publicado: (2021)

Sepsis: Personalized Medicine Utilizing ‘Omic’ Technologies—A Paradigm Shift?
por: Itenov, Theis Skovsgaard, et al.
Publicado: (2018)

Utilizing gastric cancer organoids to assess tumor biology and personalize medicine
por: Lin, Miranda, et al.
Publicado: (2019)

Mechanistic Modeling of Intra‐Tumor Spatial Distribution of Antibody‐Drug Conjugates: Insights into Dosing Strategies in Oncology
por: Weddell, Jared, et al.
Publicado: (2020)

Genomic information and a person’s right not to know: A closer look at variations in hypothetical informational preferences in a German sample
por: Flatau, Laura, et al.
Publicado: (2018)

Precision medicine for long-term depression outcomes using the Personalized Advantage Index approach: cognitive therapy or interpersonal psychotherapy?
por: van Bronswijk, Suzanne C., et al.
Publicado: (2021)

Variable Drug-Target Exposure, Tumor Signatures, and Combinatorial Targeted Treatment: Approaches of Personalized Medicine in Breast Cancer
por: Schroth, Werner, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_48f7rni2svq17kgpbaotomuj51